Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits of Amantadine in Patients With Coma State

NCT03443037 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03443037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits of Amantadine in Patients With Coma State
Lead sponsor
Dokuz Eylul University
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2016
Completion date
July 1, 2019
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amantadine, coma; prolonged